+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

Novavax, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Novavax, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • May 2024
  • 50 Pages
From
Comprehensive Report on Novavax Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Novavax Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Novavax, Inc. - Company Profile and SWOT Analysis - Product Thumbnail Image

Novavax, Inc. - Company Profile and SWOT Analysis

  • SWOT Analysis
  • January 2024
  • 47 Pages
From
Novavax Inc (NVAX) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Novavax Inc (NVAX) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • April 2023
  • 60 Pages
From
Loading Indicator